A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease by Roses A D, Lutz M W, Amrine-Madsen H, Saunders A M, Crenshaw D G, Sundseth S S, Huentelman M J, Welsh-Bohmer K A, Reiman E M in The pharmacogenomics journal (2010).

[PMID: 20029386] PubMed


The ¿4 allele of the apolipoprotein E (APOE) gene is currently the strongest and most highly replicated genetic factor for risk and age of onset of late-onset Alzheimer's disease (LOAD). Using phylogenetic analysis, we have identified a polymorphic poly-T variant, rs10524523, in the translocase of outer mitochondrial membrane 40 homolog (TOMM40) gene that provides greatly increased precision in the estimation of age of LOAD onset for APOE ¿3 carriers. In two independent clinical cohorts, longer lengths of rs10524523 are associated with a higher risk for LOAD. For APOE ¿3/4 patients who developed LOAD after 60 years of age, individuals with long poly-T repeats linked to APOE ¿3 develop LOAD on an average of 7 years earlier than individuals with shorter poly-T repeats linked to APOE ¿3 (70.5 ± 1.2 years versus 77.6 ± 2.1 years, P=0.02, n=34). Independent mutation events at rs10524523 that occurred during Caucasian evolution have given rise to multiple categories of poly-T length variants at this locus. On replication, these results will have clinical utility for predictive risk estimates for LOAD and for enabling clinical disease prevention studies. In addition, these results show the effective use of a phylogenetic approach for analysis of haplotypes of polymorphisms, including structural polymorphisms, which contribute to complex diseases.

[ hide abstract ]

Discussed In Paper


Rx Annotations

No dosing information annotated.